🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited for UChicago Medicine UChicagoHVC to help push the LVAD field forward! We will be 1 of 8 centers part of the initial INNOVATE trial assessing the BrioHealth Solutions

Ever run into a patient in practice where you are scratching your head to sort out if they have group 1 PH or HFpEF ? Turns out they might actually have both diseases. JACC Journals, we show how to identify these overlap pts with clinical implications authors.elsevier.com/a/1j%7E8h_GjkR…

Dr. William Cornwall discussing effects of exercise on RV function across the CV spectrum Chicago Hemodynamic Forum #ChiHemos2024

Today was the inaugural pulmonary hypertension clinic at UChicago Medicine Crown Point. A timely event for #PHAwarenessMonth. Excited to bring specialized cardiopulmonary care to northern Indiana! UChicagoCardio The Pulmonary Hypertension Association

The 7th Annual Courage and Innovation Symposium is back on February 8th! Join us at UChicago for the premier Heart Failure and Transplantation Conference - register today! courageandinnovation.com #HeartFailure #Cardiology #CardioX #CardioTwitter

On January 13, the University of Chicago Heart and Vascular Center achieved a groundbreaking milestone by becoming the first hospital in Illinois—and the Midwest—to implant the BrioVAD system as part of the INNOVATE Trial.

UChicago Medicine faculty are leading the way in heart failure therapeutics at #THT2025! From late-breaking science to cutting-edge technology, our experts are driving the conversation on the future of cardiac care. Date: Feb 11-13 Stay tuned for details on our featured sessions.

Dr. Anthony Kanelidis (Anthony Kanelidis, MD ) presents The RV-Protection Study at #THT2025. This research explores strategies to mitigate RV dysfunction following LVAD implantation. Co-authored with Jon Grinstein MD Date: Feb 13 Time: 7:36 AM ET Location: Ensemble E-F – Level 2

Celebrating Heart Failure Awareness Week by looking back at a year of innovation in UChicago Medicine’s Advanced Heart Failure Program. #HFWeek2025

2025 is off to a historic start! UChicago Medicine continues to push the boundaries of heart failure treatment. #HFWeek2025

Excited for the future of energetic modeling in heart failure. PAC Dynamic: Predicting Heart Failure Progression for Precision Care polsky.uchicago.edu/2025/02/12/pac… via Polsky Center at the University of Chicago

The 1st annual Chicago Hemodynamic Forum was a success! Check out our special report in Circ: Heart Failure reviewing the inaugural meeting ahajournals.org/doi/10.1161/CI… We're busy planning for year 2 - agenda coming shortly Save-the-date: Friday, November 14th in Chicago, IL! Chicago Hemodynamic Forum

Efficacy and safety were consistent across baseline cardiac index subgroups in PULSAR and STELLAR clinical trials, supporting use of sotatercept in PAH patients irrespective of baseline cardiac hemodynamics. 🔗: jhltonline.org/article/S1053-…

Gp 1 PH with high HFpEF probability have less clinical improvement with traditional PH therapy, compared to gp 1 PH + low HFpEF prob. Do we need more intensive PH therapy, sotatercept or HFpEF therapies for these pts? Many unknowns that need RCTs. publications.ersnet.org/content/erj/ea…

🧵1/ 🔥New Review🔥 Excited to share our new review on #MPNsm and PH out now in JACC Journals #jacccardioonc. Thrombosis is well known in MPNs, however emerging evidence suggests that HF and PH are common and contribute to 🤕&☠️. #cardioonc jacc.org/doi/10.1016/j.…

Big news in pulmonary embolism care: University of Chicago Medicine has been named a Comprehensive Pulmonary Embolism Center of Excellence by The PERT Consortium®. 🔹 1 of only 6 centers in the U.S. 🔹 The first and only in the Midwest Led by Jonathan Paul, MD (Jonathan Paul),

Save the Date! 📅 The 2nd Annual Chicago Hemodynamic Forum will take place on Friday, November 14th, at UChicago 🫀 Registration is open NOW! uchicagohemodynamics.com #Cardiology #Cardiotwitter #HeartFailure #hearthealth #heartdisease

So proud to be a part of two great teams UChicagoCardio Endeavor Health to help grow the reach of HF therapies for our patients in both northern + southern Chicago UChicagoHVC Ben Chung MD Mark Belkin Manreet Kanwar Jon Grinstein MD Leo Gozdecki, DO Gene Kim Anthony Kanelidis, MD